StockData
Autolus Therapeutics plc logo

Autolus Therapeutics plc (AUTL) stock

AUTLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3020% below fair value
$1.09−0.05 (-4.39%)

Close on Nov 17, 2026Market cap $290.12MP/E –Yield –

Autolus Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Autolus Therapeutics's total assets was $493.23M at Jun 30, 2026. For fiscal 2025 it was $589.07M, down 24.7% from the year before. The highest annual figure on record is $782.73M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$589.07M-24.7%
FY2024Dec 31, 2024$782.73M+108.5%
FY2023Dec 31, 2023$375.38M-23.4%
FY2022Dec 31, 2022$490.27M+20.9%
FY2021Dec 31, 2021$405.56M+37.8%
FY2020Dec 31, 2020$294.24M+7.7%
FY2018Sep 30, 2018$273.21M+83.8%
FY2017Sep 30, 2017$148.66M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$493.23M-31.6%
Q1 FY2026CQ1 2026Mar 31, 2026$527.07M-29.4%
Q4 FY2025CQ4 2025Dec 31, 2025$589.07M-24.7%
Q3 FY2025CQ3 2025Sep 30, 2025$661.95M-20.0%
Q2 FY2025CQ2 2025Jun 30, 2025$720.98M-15.5%
Q1 FY2025CQ1 2025Mar 31, 2025$746.34M-17.2%
Q4 FY2024CQ4 2024Dec 31, 2024$782.73M+108.5%
Q3 FY2024CQ3 2024Sep 30, 2024$827.49M+103.8%
Q2 FY2024CQ2 2024Jun 30, 2024$853.62M+89.3%
Q1 FY2024CQ1 2024Mar 31, 2024$901.44M+96.0%
Q4 FY2023CQ4 2023Dec 31, 2023$375.38M-23.4%
Q3 FY2023CQ3 2023Sep 30, 2023$406.10M+53.9%
Q2 FY2023CQ2 2023Jun 30, 2023$450.99M+43.6%
Q1 FY2023CQ1 2023Mar 31, 2023$459.97M+26.4%
Q4 FY2022CQ4 2022Dec 31, 2022$490.27M+20.9%
Q3 FY2022CQ3 2022Sep 30, 2022$263.83M-24.6%
Q2 FY2022CQ2 2022Jun 30, 2022$313.98M+6.7%
Q1 FY2022CQ1 2022Mar 31, 2022$363.99M+14.8%
Q4 FY2021CQ4 2021Dec 31, 2021$405.56M+30.6%
Q1 FY2021CQ1 2021Mar 31, 2021$349.75M+3.6%
Q4 FY2020CQ4 2020Dec 31, 2020$294.24M+7.7%
Q3 FY2020CQ3 2020Sep 30, 2020$317.08M+122.2%
Q2 FY2020CQ2 2020Jun 30, 2020$310.55M+108.9%
Q1 FY2020CQ1 2020Mar 31, 2020$337.66M–
Q4 FY2018CQ3 2018Sep 30, 2018$273.21M–
Q1 FY2018CQ4 2017Dec 31, 2017$142.72M–
Q4 FY2017CQ3 2017Sep 30, 2017$148.66M–

More Autolus Therapeutics figures

See a number that looks wrong?